PTGX
NASDAQ · Biotechnology
Protagonist Therapeutics Inc
$144.98
+1.98 (+1.38%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+124.74%
YTD
+66.30%
Open$143.22
Previous Close$143.00
Day High$145.37
Day Low$141.09
52W High$160.81
52W Low$58.91
Volume—
Avg Volume541.9K
Market Cap9.30B
P/E Ratio112.15
EPS$1.04
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$85.10
Above
SMA 200
$67.75
Above
RSI (14)
58.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-79.0% upside
Current
$144.98
$144.98
Target
$30.47
$30.47
$24.78
$30.47 avg
$49.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 47.07M | 39.20M | 743.95M |
| Net Income | -133,119,251 | -99,781,232 | -91,860,800 |
| Profit Margin | -282.8% | -268.7% | -12.4% |
| EBITDA | -160,429,766 | -126,932,853 | -161,541,358 |
| Free Cash Flow | — | — | -86,698,990 |
| Rev Growth | +20.1% | +20.1% | +6.6% |
| Debt/Equity | — | — | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |